GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » FOXO Technologies Inc (AMEX:FOXO) » Definitions » Change In Receivables

FOXO (FOXO Technologies) Change In Receivables : $0.00 Mil (TTM As of Sep. 2024)


View and export this data going back to 2022. Start your Free Trial

What is FOXO Technologies Change In Receivables?

FOXO Technologies's change in receivables for the quarter that ended in Sep. 2024 was $0.00 Mil. It means FOXO Technologies's Accounts Receivable stayed the same from Jun. 2024 to Sep. 2024 .

FOXO Technologies's change in receivables for the fiscal year that ended in Dec. 2023 was $18.57 Mil. It means FOXO Technologies's Accounts Receivable declined by $18.57 Mil from Dec. 2022 to Dec. 2023 .

FOXO Technologies's Accounts Receivable for the quarter that ended in Sep. 2024 was $2.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. FOXO Technologies's Days Sales Outstanding for the three months ended in Sep. 2024 was 152.67.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. FOXO Technologies's liquidation value for the three months ended in Sep. 2024 was $-58.59 Mil.

FOXO Technologies Change In Receivables Historical Data

The historical data trend for FOXO Technologies's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

FOXO Technologies Change In Receivables Chart

FOXO Technologies Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Change In Receivables
- 0.31 0.89 18.57

FOXO Technologies Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

FOXO Technologies Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

FOXO Technologies  (AMEX:FOXO) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

FOXO Technologies's Days Sales Outstanding for the quarter that ended in Sep. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=2.001/1.196*91
=152.67

2. In Ben Graham's calculation of liquidation value, FOXO Technologies's accounts receivable are only considered to be worth 75% of book value:

FOXO Technologies's liquidation value for the quarter that ended in Sep. 2024 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=0.034-60.225+0.75 * 2.001+0.5 * 0.21
=-58.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

FOXO Technologies Change In Receivables Related Terms

Thank you for viewing the detailed overview of FOXO Technologies's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

FOXO Technologies Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » FOXO Technologies Inc (AMEX:FOXO) » Definitions » Change In Receivables
Comparable Companies
NHIQ WLSS HITC ACON WORX KERN LGMK OTRK INQR VYND GEHC VEEV TSE:2413 HQY ASX:PME RCM TXG DOCS PGNY TDOC
Traded in Other Exchanges
N/A
Address
729 Washington Avenue N, Suite 600, Minneapolis, MN, USA, 55401
Website
https://foxotechnologies.com
FOXO Technologies Inc is a technology platform company focused on commercializing longevity science through products and services that serve the life insurance industry. FOXO's epigenetic technology applies AI to DNA methylation to identify molecular biomarkers of human health and aging. The company has two reportable business segments, FOXO Labs and FOXO Life.
Executives
Martin Christopher Ward officer: Interim CFO CHALKSTREAM, KINGS SOMBORNE, STOCKBRIDGE X0 S020 6NZ
Mark Brian White director, officer: Interim CEO IMMEUBLE MILA, CHAMPERY V8 1874
Dowling Vincent J. Jr 10 percent owner 54 LEDYARD, WEST HARTFORD CT 06117
Gwg Holdings, Inc. 10 percent owner 325 N. ST. PAUL STREET, SUITE 2650, DALLAS TX 75201
Taylor Fay officer: Chief Operating Officer 729 N. WASHINGTON AVE, SUITE 600, MINNEAPOLIS MN 55401
Jon Sabes director, 10 percent owner, officer: CEO, Chairman 701 NORTH THIRD STREET, MINNEAPOLIS MN 55401
Bret Barnes director 220 SOUTH SIXTH STREET, MINNEAPOLIS MN 55402
Brian Chen officer: Chief Science Officer 220 SOUTH SIXTH STREET, SUITE 1200, MINNEAPOLIS MN 55402
Erin Sharoni officer: Chief Product Officer 220 SOUTH SIXTH STREET, SUITE 1200, MINNEAPOLIS MN 55402
Michael Will officer: General Counsel 220 SOUTH SIXTH STREET, SUITE 1200, MINNEAPOLIS MN 55402
Tyler Danielson officer: Chief Technology Officer 220 SOUTH SIXTH STREET, SUITE 1200, MINNEAPOLIS MN 55402
Murdoc Khaleghi director 220 SOUTH SIXTH STREET, SUITE 1200, MINNEAPOLIS MN 55402
Robert Potashnick officer: Chief Financial Officer 220 SOUTH SIXTH STREET, SUITE 1200, MINNEAPOLIS MN 55402
Plc Barclays 10 percent owner 1 CHURCHILL PLACE, CANARY WHARF, LONDON X0 E14 5HP
Paul Britton Newhouse director ONE CITY CENTRE, 1021 MAIN STREET SUITE 1960, HOUSTON TX 77002